Andreia Rafaela Linhares Miranda

Verified @hotmail.com

Experimental Pathology and Therapeutics Group
Portuguese Oncology Institute of Porto (IPO-Porto)

37

Scholar Citations

3

Scholar h-index

2

Scholar i10-index

RECENT SCHOLAR PUBLICATIONS

  • Immunomodulatory glycomedicine: Introducing next generation cancer glycovaccines
    R Freitas, A Peixoto, E Ferreira, A Miranda, LL Santos, JA Ferreira
    Biotechnology Advances, 108144 2023

  • A roadmap for translational cancer glycoimmunology at single cell resolution
    A Peixoto, A Miranda, LL Santos, JA Ferreira
    Journal of Experimental & Clinical Cancer Research 41 (1), 143 2022

  • Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion
    C Gaiteiro, J Soares, M Relvas-Santos, A Peixoto, D Ferreira, P Paulo, ...
    Theranostics 12 (7), 3150 2022

  • Glycoproteogenomics characterizes the CD44 splicing code driving bladder cancer invasion
    C Gaiteiro, J Soares, M Relvas-Santos, A Peixoto, D Ferreira, A Brando, ...
    bioRxiv, 2021.09. 04.458979 2021

MOST CITED SCHOLAR PUBLICATIONS

  • Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion
    C Gaiteiro, J Soares, M Relvas-Santos, A Peixoto, D Ferreira, P Paulo, ...
    Theranostics 12 (7), 3150 2022
    Citations: 18

  • Immunomodulatory glycomedicine: Introducing next generation cancer glycovaccines
    R Freitas, A Peixoto, E Ferreira, A Miranda, LL Santos, JA Ferreira
    Biotechnology Advances, 108144 2023
    Citations: 11

  • A roadmap for translational cancer glycoimmunology at single cell resolution
    A Peixoto, A Miranda, LL Santos, JA Ferreira
    Journal of Experimental & Clinical Cancer Research 41 (1), 143 2022
    Citations: 7

  • Glycoproteogenomics characterizes the CD44 splicing code driving bladder cancer invasion
    C Gaiteiro, J Soares, M Relvas-Santos, A Peixoto, D Ferreira, A Brando, ...
    bioRxiv, 2021.09. 04.458979 2021
    Citations: 1